A 38-year-old woman who had a past history of repeatedly hemoptysis 10 years earlier was admitted with the complaint of a small amount of haemoptysis on April 6, 2013.
A 38-year-old woman who had a past history of repeatedly hemoptysis 10 years earlier was admitted with the complaint of a small amount of haemoptysis on April 6, 2013.
Objective To evaluate whether elevated plasma levels of soluble receptor for advanced glycation end products (sRAGE) and S100A12 reflected impaired lung function children after cardiac surgery necessitating cardiopulm...
Objective To evaluate whether elevated plasma levels of soluble receptor for advanced glycation end products (sRAGE) and S100A12 reflected impaired lung function children after cardiac surgery necessitating cardiopulmonary bypass (CPB).
Objective To study how a prototypical HAT from the GNAT family, GCN5 (general control nonrepressed-protein 5, KAT2A), contributes to host alloresponses and epigenetic mechanism.
Objective To study how a prototypical HAT from the GNAT family, GCN5 (general control nonrepressed-protein 5, KAT2A), contributes to host alloresponses and epigenetic mechanism.
Objective Retrograde type A aortic dissection (RTAD) is a life-threatening and underestimated complication of endovascular stent graft placement for type B *** retrospectively investigated our experience of surgical t...
Objective Retrograde type A aortic dissection (RTAD) is a life-threatening and underestimated complication of endovascular stent graft placement for type B *** retrospectively investigated our experience of surgical treatment for RTAD after endovascular stent graft placement for type B dissection.
Background Accurate clinical stage affect the therapeutic modality for NSCLC patients, we aimed to identify the significant predictive risk factors for N2 metastasis in clinical stage IA NSCLC patients.
Background Accurate clinical stage affect the therapeutic modality for NSCLC patients, we aimed to identify the significant predictive risk factors for N2 metastasis in clinical stage IA NSCLC patients.
暂无评论